Source: PLOS ONE. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
ZAGO, Cláudia Augusta et al. Anti-IL-2 treatment impairs the expansion of Treg cell population during acute malaria and enhances the Th1 cell response at the chronic disease. PLOS ONE, v. 7, n. 1, p. 1-9, 2012Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0029894. Acesso em: 01 set. 2024.APA
Zago, C. A., Bortoluci, K. R., Sardinha, L. R., Pretel, F. D., Castillo-Méndez, S. I., Rosário, A. P. F. do, et al. (2012). Anti-IL-2 treatment impairs the expansion of Treg cell population during acute malaria and enhances the Th1 cell response at the chronic disease. PLOS ONE, 7( 1), 1-9. doi:10.1371/journal.pone.0029894NLM
Zago CA, Bortoluci KR, Sardinha LR, Pretel FD, Castillo-Méndez SI, Rosário APF do, Hiyane MI, Muxel SM, Rodriguez-Málaga SM, Abrahamsohn I de A, Alvarez JM, Lima MRD'I. Anti-IL-2 treatment impairs the expansion of Treg cell population during acute malaria and enhances the Th1 cell response at the chronic disease [Internet]. PLOS ONE. 2012 ; 7( 1): 1-9.[citado 2024 set. 01 ] Available from: https://doi.org/10.1371/journal.pone.0029894Vancouver
Zago CA, Bortoluci KR, Sardinha LR, Pretel FD, Castillo-Méndez SI, Rosário APF do, Hiyane MI, Muxel SM, Rodriguez-Málaga SM, Abrahamsohn I de A, Alvarez JM, Lima MRD'I. Anti-IL-2 treatment impairs the expansion of Treg cell population during acute malaria and enhances the Th1 cell response at the chronic disease [Internet]. PLOS ONE. 2012 ; 7( 1): 1-9.[citado 2024 set. 01 ] Available from: https://doi.org/10.1371/journal.pone.0029894